Clinical Remission Using Personalized Low-Dose Intravenous Infusions of <i>N</i>-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome

Clinical Remission Using Personalized Low-Dose Intravenous Infusions of <i>N</i>-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome

Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, IL-8, IL-10, TNF-α, and is associated with debilitating symptoms of pelvic pain and frequent urination. A standard of care for IC/BPS has not...

Full description

Bibliographic Details
Main Authors: Dipnarine Maharaj, Gayathri Srinivasan, Sarah Makepeace, Christopher J. Hickey, Jacqueline Gouvea
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Personalized Medicine
Subjects:
interstitial cystitis
bladder pain syndrome
<i>N</i>-acetylcysteine
personalized medicine
pro-inflammatory cytokines
inflammation
Online Access:https://www.mdpi.com/2075-4426/11/5/342

Similar Items

Similar Items